Zdrowie i gospodarka · 08/08/2007

FDA Classifies In Vitro HIV Drug Resistance Genotype Assay Under Special Controls

The FDA is classifying an in vitro HIV drug resistance genotype assay into Class II, a category requiring special controls, to ensure the device's safety and effectiveness. The FDA has published a guidance document outlining these controls, which will be available for public review.